In recent years, it has become evident that astrocytes harbor functional re
ceptors to many neurotransmitters, including substance P (SP), an undecapep
tide belonging to the tachykinin family of neuropeptides. SP is an importan
t stimulus fur reactive astrocytes in CNS development, infection and injury
, and provides a link for bi-directional interactions between glial cells a
nd neurons. In brain tumors, malignant glial cells originating from astrocy
tes, via NK, receptors, are triggered by tachykinins, SP and neurokinin A (
NKA), to release soluble mediators, in particular cytokines, and increase t
heir proliferative rate. In this paper, we review the results obtained in i
pl vitro and in vivo studies on the role of SP as an inducer of human gliom
a responses that may be relevant for tumor progression. In addition, the pr
esence of SP and the expression of NK1 receptors in glioma explants have be
en examined. We discuss the possible use of selective NK1 receptor antagoni
sts as a therapeutic approach to treat malignant gliomas. (C) 2000 Elsevier
Science Inc. All rights reserved.